Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Wong

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
Growth Factors (Chur, Switzerland)|March 29, 2021
Immunohistochemical evaluation of the prognostic and predictive power of epidermal growth factor receptor ligand levels in patients with metastatic colorectal cancerSiavash Foroughi, Ryan A Hutchinson, Hui-Li Wong, et al.
Internal Medicine Journal|December 8, 2019
Dose modification for haematological toxicity: a survey of Australian medical oncologistsWanyuan Cui, Julia Shingleton, Liesel Byrne, et al.
The Lancet. Planetary Health|January 7, 2023
The World Organization of Family Doctors Air Health Train the Trainer Program: lessons learned and implications for planetary health educationAlice McGushin, Enrique Falceto de Barros, Mayara Floss, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2026
IL-6 Receptor Antagonists and Severe Post-COVID-19 Outcomes: An Emulated Target TrialZachary Butzin-Dozier, Manav Kumar, Yunwen Ji, et al.
Pharmacoeconomics|June 5, 2021
Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal CancerYat Hang To, Koen Degeling, Suzanne Kosmider, et al.
Journal of the American Medical Informatics Association : JAMIA|May 19, 2023
Characterizing terminology applied by authors and database producers to informatics literature on consumer engagement with wearable devicesKristine M Alpi, Christie L Martin, Joseph M Plasek, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|July 1, 2026
Aligning Thrombophilia Testing With Evidence-Based Guidelines: The Impact of Clinical Decision Support Redesign in an Academic Medical CenterLyncean Ung, Marcus H Lee, Suguna Raju, et al.
Targeted Oncology|February 18, 2021
BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?Vanessa Wong, Margaret Lee, Rachel Wong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 16, 2020
Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial)Sweet Ping Ng, Julie Chu, Sarat Chander, et al.
Clinical Colorectal Cancer|January 19, 2024
Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer RecurrenceOliver Piercey, Hui-Li Wong, Clara Leung, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Growth Factors (Chur, Switzerland)|March 29, 2021
Immunohistochemical evaluation of the prognostic and predictive power of epidermal growth factor receptor ligand levels in patients with metastatic colorectal cancerSiavash Foroughi, Ryan A Hutchinson, Hui-Li Wong, et al.
Internal Medicine Journal|December 8, 2019
Dose modification for haematological toxicity: a survey of Australian medical oncologistsWanyuan Cui, Julia Shingleton, Liesel Byrne, et al.
The Lancet. Planetary Health|January 7, 2023
The World Organization of Family Doctors Air Health Train the Trainer Program: lessons learned and implications for planetary health educationAlice McGushin, Enrique Falceto de Barros, Mayara Floss, et al.
Medrxiv : the Preprint Server for Health Sciences|March 13, 2026
IL-6 Receptor Antagonists and Severe Post-COVID-19 Outcomes: An Emulated Target TrialZachary Butzin-Dozier, Manav Kumar, Yunwen Ji, et al.
Pharmacoeconomics|June 5, 2021
Circulating Tumour DNA as a Potential Cost-Effective Biomarker to Reduce Adjuvant Chemotherapy Overtreatment in Stage II Colorectal CancerYat Hang To, Koen Degeling, Suzanne Kosmider, et al.
Journal of the American Medical Informatics Association : JAMIA|May 19, 2023
Characterizing terminology applied by authors and database producers to informatics literature on consumer engagement with wearable devicesKristine M Alpi, Christie L Martin, Joseph M Plasek, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|July 1, 2026
Aligning Thrombophilia Testing With Evidence-Based Guidelines: The Impact of Clinical Decision Support Redesign in an Academic Medical CenterLyncean Ung, Marcus H Lee, Suguna Raju, et al.
Targeted Oncology|February 18, 2021
BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?Vanessa Wong, Margaret Lee, Rachel Wong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 16, 2020
Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial)Sweet Ping Ng, Julie Chu, Sarat Chander, et al.
Clinical Colorectal Cancer|January 19, 2024
Adjuvant Chemotherapy for Older Patients With Stage III Colorectal Cancer: A Real-World Analysis of Treatment Recommendations, Treatment Administered and Impact on Cancer RecurrenceOliver Piercey, Hui-Li Wong, Clara Leung, et al.
Pageof 19